According to Genetic Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.617247. At the end of 2008 the company had a P/S ratio of 1.85.
Year | P/S ratio | Change |
---|---|---|
2008 | 1.85 | -40.16% |
2007 | 3.09 | -78.5% |
2006 | 14.4 | -21.63% |
2005 | 18.3 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 5.30 | 759.00% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 1.73 | 179.73% | ๐บ๐ธ USA |
Danaher DHR | 8.74 | 1,316.39% | ๐บ๐ธ USA |
LabCorp LH | 1.44 | 133.81% | ๐บ๐ธ USA |
Compugen CGEN | 5.82 | 842.69% | ๐ฎ๐ฑ Israel |
Neogen NEOG | 3.16 | 411.34% | ๐บ๐ธ USA |
Myriad Genetics MYGN | 3.04 | 392.73% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 159 | 25,680.12% | ๐บ๐ธ USA |